Ondansetron: a selective 5-HT(3) receptor antagonist and its applications in CNS-related disorders. (Q34320153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11474424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Ondansetron: a selective 5-HT(3) receptor antagonist and its applications in CNS-related disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11474424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

J H Ye

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11474424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R Ponnudurai

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11474424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R Schaefer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11474424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11474424%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11474424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11474424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11474424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

199-213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11474424%20AND%20SRC:MED&resulttype=core&format=json

Comparison of ondansetron with ondansetron and dexamethasone in prevention of PONV in diagnostic laparoscopy

9 November 2019

cites work

1 reference

12 December 2020

5HT antagonists attenuate MK801-impaired radial arm maze performance in rats.

1 reference

12 December 2020

Psychosis: impact on the patient and family

1 reference

12 December 2020

ASHP Therapeutic Guidelines on the Pharmacologic Management of Nausea and Vomiting in Adult and Pediatric Patients Receiving Chemotherapy or Radiation Therapy or Undergoing Surgery

1 reference

12 December 2020

Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents

1 reference

12 December 2020

Cost-effectiveness of ondansetron for postoperative nausea and vomiting

1 reference

12 December 2020

Inhibitory effect of ondansetron on glycine response of dissociated rat hippocampal neurons.

1 reference

12 December 2020

5-HT3 receptors and the neural actions of alcohols: an increasingly exciting topic

1 reference

12 December 2020

Management of opioid-induced pruritus: a role for 5-HT3 antagonists?

1 reference

12 December 2020

A review of central 5-HT receptors and their function

1 reference

12 December 2020

Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group

1 reference

12 December 2020

Serotonin receptor physiology: relation to emesis

1 reference

12 December 2020

Antiemetic therapy for high-dose chemotherapy with transplantation: report of a retrospective analysis of a 5-HT(3) regimen and literature review

1 reference

12 December 2020

Ondansetron treatment in patients with Tourette's syndrome

1 reference

12 December 2020

Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Ondansetron OIE Post-Surgical Study Group

1 reference

12 December 2020

Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis

1 reference

12 December 2020

Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia

1 reference

12 December 2020

Acute myocardial ischemia after administration of ondansetron hydrochloride

1 reference

12 December 2020

Prevention and treatment of postoperative nausea and vomiting

1 reference

12 December 2020

1 reference

12 December 2020

The cost-effective management of postoperative nausea and vomiting

1 reference

12 December 2020

Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist

1 reference

12 December 2020

Intrathecal fentanyl is superior to intravenous ondansetron for the prevention of perioperative nausea during cesarean delivery with spinal anesthesia

1 reference

12 December 2020

Ondansetron therapy for uremic pruritus in hemodialysis patients.

1 reference

12 December 2020

Prophylactic intravenous ondansetron reduces the incidence of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery

1 reference

12 December 2020

Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

1 reference

12 December 2020

Medications to treat alcoholism.

1 reference

12 December 2020

A randomized, double-blinded comparison of ondansetron, droperidol, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy

1 reference

12 December 2020

Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial

1 reference

12 December 2020

Effects of ondansetron pretreatment on acute responses to ethanol in social drinkers

1 reference

12 December 2020

Serotonin (5-hydroxytryptamine)

1 reference

12 December 2020

The role of 5-HT in postoperative nausea and vomiting

1 reference

12 December 2020

5-HT3 antagonists in postoperative nausea and vomiting

1 reference

12 December 2020

Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow

1 reference

12 December 2020

Ligand-gated ion channels in the brain: the amino acid receptor superfamily

1 reference

12 December 2020

Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation

1 reference

12 December 2020

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

1 reference

12 December 2020

The concept of selectivity in 5-HT receptor research

1 reference

12 December 2020

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

1 reference

12 December 2020

Antiemetic properties of the 5HT3-receptor antagonist, GR38032F

1 reference

12 December 2020

Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors

1 reference

12 December 2020

Evidence for an extra-abdominal site of action for the 5-HT3 receptor antagonist BRL24924 in the inhibition of radiation-evoked emesis in the ferret

1 reference

12 December 2020

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)

1 reference

12 December 2020

Effects of 5-HT3 receptor antagonists on binding and function of mouse and human GABAA receptors

1 reference

12 December 2020

The physiology and pharmacology of postoperative nausea and vomiting

1 reference

12 December 2020

Risk factors for postoperative nausea and vomiting

1 reference

12 December 2020

Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?

1 reference

12 December 2020

Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron)

1 reference

12 December 2020

Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment

1 reference

12 December 2020

Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine

1 reference

12 December 2020

Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications

1 reference

12 December 2020

A quantitative systematic review of ondansetron in treatment of established postoperative nausea and vomiting

1 reference

12 December 2020

Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model

1 reference

12 December 2020

5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy

1 reference

12 December 2020

A Comparison of the Prophylactic Antiemetic Effect of Ondansetron and Droperidol on Patients Undergoing Gynecologic Laparoscopy

1 reference

12 December 2020

5-HT3 receptor antagonists: Differences and similarities

1 reference

12 December 2020

Ondansetron Exhibits the Properties of a Local Anesthetic

1 reference

12 December 2020

Ondansetron modulates GABAA current of rat central nervous system neurons

1 reference

12 December 2020

Effects of the 5-HT3 Antagonist, Ondansetron, on the Behavioral and Physiological Effects of Pentagastrin in Patients with Panic Disorder and Social Phobia

1 reference

12 December 2020

5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy

1 reference

12 December 2020

Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs

1 reference

12 December 2020

Effects of ondansetron administration on opioid withdrawal syndrome observed in rats

1 reference

12 December 2020

The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test

1 reference

12 December 2020

A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation

1 reference

12 December 2020

Level of punishment determines anticonflict activity of ondansetron in pigeons: comparison with buspirone and diazepam

1 reference

12 December 2020

Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial

1 reference

12 December 2020

Ondansetron is effective to treat spinal or epidural morphine-induced pruritus

1 reference

12 December 2020

10.1111/J.1527-3458.2001.TB00195.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11474424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11474424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

PubMed publication ID

11474424

1 reference